Exploring erythropoietin and G-CSF combination therapy in chronic stroke patients

International Journal of Molecular Sciences

Volumn 17, Issue 4, 2016, Pages

  Shin, Yoon Kyum ^a   Cho, Sung Rae ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei Stem Cell Center   (South Korea)

Author keywords

Combination therapy; Erythropoietin; Granulocyte colony stimulating factor; Neuroprotection; Stroke

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO; CD34 ANTIGEN; NEUROPROTECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; BACKACHE; BARTHEL INDEX; BLOOD SAMPLING; BRAIN ISCHEMIA; CD34+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOLLOW UP; HEADACHE; HEART RATE; HUMAN; IMMUNOASSAY; LEUKOCYTE; MALE; MINI MENTAL STATE EXAMINATION; MULTIPLE CYCLE TREATMENT; NEUTROPHIL; OUTCOME ASSESSMENT; POWER GRIP; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE; VOMITING; CHRONIC DISEASE; COMBINATION DRUG THERAPY; CYTOLOGY; HEMATOPOIETIC STEM CELL; METABOLISM; MIDDLE AGED; PILOT STUDY; PLACEBO EFFECT; STROKE;

ADULT; ANTIGENS, CD34; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPOETIN ALFA; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUTROPHILS; PILOT PROJECTS; PLACEBO EFFECT; STROKE;

EID: 84962092254     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17040463     Document Type: Article

References (43)

1. Ehrenreich, H.; Hasselblatt, M.; Dembowski, C.; Cepek, L.; Lewczuk, P.; Stiefel, M.; Rustenbeck, H.H.; Breiter, N.; Jacob, S.; Knerlich, F.; et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 2002, 8, 495-505. [PubMed]
2. Ehrenreich, H.; Weissenborn, K.; Prange, H.; Schneider, D.; Weimar, C.; Wartenberg, K.; Schellinger, P.D.; Bohn, M.; Becker, H.; Wegrzyn, M.; et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009, 40, 647-656. [CrossRef] [PubMed]
3. Hasselblatt, M.; Jeibmann, A.; Riesmeier, B.; Maintz, D.; Schabitz, W.R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 2007, 113, 45-51. [CrossRef] [PubMed]
4. Springborg, J.B.; Moller, C.; Gideon, P.; Jorgensen, O.S.; Juhler, M.; Olsen, N.V. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: A double blind randomised clinical trial. Acta Neurochir. 2007, 149, 1089-1101. [CrossRef] [PubMed]
5. Tseng, M.Y.; Hutchinson, P.J.; Richards, H.K.; Czosnyka, M.; Pickard, J.D.; Erber, W.N.; Brown, S.; Kirkpatrick, P.J. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: A Phase II randomized, double-blind, placebo-controlled trial. Clinical article. J. Neurosurg. 2009, 111, 171-180. [CrossRef] [PubMed]
6. Minnerup, J.; Schabitz, W.R. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 2009, 6, 43-52. [CrossRef] [PubMed]
7. Zaleska, M.M.; Mercado, M.L.; Chavez, J.; Feuerstein, G.Z.; Pangalos, M.N.; Wood, A. The development of stroke therapeutics: Promising mechanisms and translational challenges. Neuropharmacology 2009, 56, 329-341. [CrossRef] [PubMed]
8. Bessho, M.; Jinnai, I.; Matsuda, A.; Saito, M.; Hirashima, K. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int. J. Cell Cloning 1990, 8, 445-458. [CrossRef] [PubMed]
9. Rose, E.H.; Abels, R.I.; Nelson, R.A.; McCullough, D.M.; Lessin, L. The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS). Br. J. Haematol. 1995, 89, 831-837. [CrossRef] [PubMed]
10. Rader, M. Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: Clinical and economic benefits. Oncology 2006, 20, 16-21. [PubMed]
11. Morris, C.L.; Siegel, E.; Barlogie, B.; Cottler-Fox, M.; Lin, P.; Fassas, A.; Zangari, M.; Anaissie, E.; Tricot, G. Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: Influence of age, prior therapy, platelet count and mobilization regimen. Br. J. Haematol. 2003, 120, 413-423. [CrossRef] [PubMed]
12. Li, Y.; Chen, J.; Chopp, M. Adult bone marrow transplantation after stroke in adult rats. Cell Transplant. 2001, 10, 31-40. [PubMed]
13. Chen, J.; Zhang, Z.G.; Li, Y.; Wang, L.; Xu, Y.X.; Gautam, S.C.; Lu, M.; Zhu, Z.; Chopp, M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 2003, 92, 692-699. [CrossRef] [PubMed]
14. Liu, Z.; Li, Y.; Zhang, Z.G.; Cui, X.; Cui, Y.; Lu, M.; Savant-Bhonsale, S.; Chopp, M. Bone marrow stromal cells enhance inter-and intracortical axonal connections after ischemic stroke in adult rats. J. Cereb. Blood Flow Metab. 2010, 30, 1288-1295. [CrossRef] [PubMed]
15. Ng, T.; Marx, G.; Littlewood, T.; Macdougall, I. Recombinant erythropoietin in clinical practice. Postgrad. Med. J. 2003, 79, 367-376. [CrossRef] [PubMed]
16. Siren, A.L.; Fasshauer, T.; Bartels, C.; Ehrenreich, H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009, 6, 108-127. [CrossRef] [PubMed]
17. Schneider, A.; Kuhn, H.G.; Schabitz,W.R. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 2005, 4, 1753-1757. [PubMed]
18. Schabitz, W.R.; Schneider, A. New targets for established proteins: Exploring G-CSF for the treatment of stroke. Trends Pharmacol. Sci. 2007, 28, 157-161. [CrossRef] [PubMed]
19. Bath, P.M.; Sprigg, N.; England, T. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst. Rev. 2013, 6. [CrossRef]
20. De La Pena, I.; Sanberg, P.R.; Acosta, S.; Lin, S.Z.; Borlongan, C.V. G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. Cell Transplant. 2015, 24, 447-457. [CrossRef] [PubMed]
21. Shyu,W.C.; Lin, S.Z.; Lee, C.C.; Liu, D.D.; Li, H. Granulocyte colony-stimulating factor for acute ischemic stroke: A randomized controlled trial. CMAJ 2006, 174, 927-933. [CrossRef] [PubMed]
22. Sprigg, N.; Bath, P.M.; Zhao, L.; Willmot, M.R.; Gray, L.J.; Walker, M.F.; Dennis, M.S.; Russell, N. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: The Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006, 37, 2979-2983. [CrossRef] [PubMed]
23. Floel, A.; Warnecke, T.; Duning, T.; Lating, Y.; Uhlenbrock, J.; Schneider, A.; Vogt, G.; Laage, R.; Koch,W.; Knecht, S.; et al. Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease-A randomized controlled trial. PLoS ONE 2011, 6, e19767. [CrossRef] [PubMed]
24. England, T.J.; Abaei, M.; Auer, D.P.; Lowe, J.; Jones, D.R.; Sare, G.; Walker, M.; Bath, P.M. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: The stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 2012, 43, 405-411. [CrossRef] [PubMed]
25. Rogalewski, A.; Schneider, A.; Ringelstein, E.B.; Schabitz, W.R. Toward a multimodal neuroprotective treatment of stroke. Stroke 2006, 37, 1129-1136. [PubMed]
26. Schabitz, W.R.; Kruger, C.; Pitzer, C.; Weber, D.; Laage, R.; Gassler, N.; Aronowski, J.; Mier, W.; Kirsch, F.; Dittgen, T.; et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 2008, 28, 29-43. [CrossRef] [PubMed]
27. Floel, A.; Cohen, L.G. Recovery of function in humans: Cortical stimulation and pharmacological treatments after stroke. Neurobiol. Dis. 2010, 37, 243-251. [CrossRef] [PubMed]
28. Sutherland, B.A.; Minnerup, J.; Balami, J.S.; Arba, F.; Buchan, A.M.; Kleinschnitz, C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside. Int. J. Stroke 2012, 7, 407-418. [CrossRef] [PubMed]
29. Ehrenreich, H.; Fischer, B.; Norra, C.; Schellenberger, F.; Stender, N.; Stiefel, M.; Siren, A.L.; Paulus, W.; Nave, K.A.; Gold, R.; et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007, 130, 2577-2588. [CrossRef] [PubMed]
30. Liu, S.P.; Lee, S.D.; Lee, H.T.; Liu, D.D.;Wang, H.J.; Liu, R.S.; Lin, S.Z.; Su, C.Y.; Li, H.; Shyu,W.C. Granulocyte colony-stimulating factor activating HIF-1α acts synergistically with erythropoietin to promote tissue plasticity. PLoS ONE 2010, 5, e10093. [CrossRef]
31. Rosser, N.; Floel, A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation 2008, 23, 95-103. [PubMed]
32. Minnerup, J.;Wersching, H.; Schabitz,W.R. Erythropoietin for stroke treatment: Dead or alive? Crit. Care 2011, 15, 129. [CrossRef] [PubMed]
33. Yu, J.H.; Seo, J.H.; Lee, J.E.; Heo, J.H.; Cho, S.R. Time-dependent effect of combination therapy with erythropoietin and granulocyte colony-stimulating factor in a mouse model of hypoxic-ischemic brain injury. Neurosci. Bull. 2014, 30, 107-117. [CrossRef] [PubMed]
34. Hellstrom-Lindberg, E.; van de Loosdrecht, A. Erythropoiesis stimulating agents and other growth factors in low-risk MDS. Best Pract. Res. Clin. Haematol. 2013, 26, 401-410. [CrossRef] [PubMed]
35. Kasper, C.; Zahner, J.; Sayer, H.G. Recombinant human erythropoietin in combined treatment with granulocyte-or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. J. Cancer Res. Clin. Oncol. 2002, 128, 497-502. [PubMed]
36. Terpos, E.; Mougiou, A.; Kouraklis, A.; Chatzivassili, A.; Michalis, E.; Giannakoulas, N.; Manioudaki, E.; Lazaridou, A.; Bakaloudi, V.; Protopappa, M.; et al. Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: A phase II trial in 281 patients. Br. J. Haematol. 2002, 118, 174-180. [CrossRef] [PubMed]
37. Casadevall, N.; Durieux, P.; Dubois, S.; Hemery, F.; Lepage, E.; Quarre, M.C.; Damaj, G.; Giraudier, S.; Guerci, A.; Laurent, G.; et al. Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: A randomized, controlled trial. Blood 2004, 104, 321-327. [CrossRef] [PubMed]
38. Haljan, G.; Maitland, A.; Buchan, A.; Arora, R.C.; King, M.; Haigh, J.; Culleton, B.; Faris, P.; Zygun, D. The erythropoietin neuroprotective effect: Assessment in CABG surgery (TENPEAKS): A randomized, double-blind, placebo controlled, proof-of-concept clinical trial. Stroke 2009, 40, 2769-2775. [CrossRef] [PubMed]
39. Vangijn, J.; Rinkel, G.J. Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 2001, 124, 249-278. [CrossRef]
40. Cumming, T.B.; Churilov, L.; Linden, T.; Bernhardt, J. Montreal cognitive assessment and mini-mental state examination are both valid cognitive tools in stroke. Acta Neurol. Scand. 2013, 128, 122-129. [CrossRef] [PubMed]
41. Quinn, T.J.; Langhorne, P.; Stott, D.J. Barthel index for stroke trials: Development, properties, and application. Stroke 2011, 42, 1146-1151. [CrossRef] [PubMed]
42. Chang, M.; Jung, N.H. comparison of task performance, hand power, and dexterity with and without a cock-up splint. J. Phys. Ther. Sci. 2013, 25, 1429-1431. [CrossRef] [PubMed]
43. Chanubol, R.;Wongphaet, P.; Chavanich, N.;Werner, C.; Hesse, S.; Bardeleben, A.; Merholz, J. A randomized controlled trial of cognitive sensory motor training therapy on the recovery of arm function in acute stroke patients. Clin. Rehabil. 2012, 26, 1096-1104. [CrossRef] [PubMed]